? ? Studies are proposed to characterize a novel gene DOC45 (DNA damage-regulated overexpressed in cancer 45) that encodes a highly conserved putative GTP-binding protein of 45 kDa. GTP-binding proteins control various important processes including, protein translation and trafficking, signal transduction, cell growth, survival and transformation. Preliminary results presented here indicate that DOC45 mRNA expression is down-regulated by genotoxic stress (DNA damage) as well as by tumor suppressor p53. However, DOC45 down-regulation following genotoxic stress appears to also occur in a p53-independent manner. In addition, DOC45 is overexpressed in several cancer types including colorectal cancer. Based on our preliminary results, we hypothesize that DOC45 could be a high-value tumor marker and its down-regulation by DNA damage and p53 may be a critical event for DNA damage and p53-mediated growth inhibition and/or cell death. Furthermore, alterations in DOC45 expression and DOC45-mediated signaling events could be part of the mechanisms underlying the development and/or progression of selected human malignancies including colorectal cancer. We have proposed two specific aims to further characterize DOC45.
Specific Aim 1 is to investigate the expression of DOC45, at mRNA as well as protein levels, in primary colorectal cancers and matching normal tissues.
Specific Aim 2 is to determine the GTP-binding potential of DOC45 and its role in cellular response to DNA damage. The outcome of these studies will provide valuable information about the utility of DOC45 as a high-value molecular tumor marker, and its role in DNA damage response particularly in context to the development and/or progression of human colorectal cancer. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Small Research Grants (R03)
Project #
1R03CA128096-01
Application #
7266108
Study Section
Special Emphasis Panel (ZCA1-SRRB-F (J1))
Program Officer
Wagner, Paul D
Project Start
2007-06-12
Project End
2009-05-31
Budget Start
2007-06-12
Budget End
2008-05-31
Support Year
1
Fiscal Year
2007
Total Cost
$78,333
Indirect Cost
Name
Upstate Medical University
Department
Pharmacology
Type
Schools of Medicine
DUNS #
058889106
City
Syracuse
State
NY
Country
United States
Zip Code
13210
Jiang, Lingyan; Rong, Rong; Sheikh, M Saeed et al. (2011) Cullin-4A·DNA damage-binding protein 1 E3 ligase complex targets tumor suppressor RASSF1A for degradation during mitosis. J Biol Chem 286:6971-8
Jiang, Lingyan; Luo, Xiuquan; Shi, Jingxue et al. (2011) PDRG1, a novel tumor marker for multiple malignancies that is selectively regulated by genotoxic stress. Cancer Biol Ther 11:567-73
Sun, Hong; Luo, Xiuquan; Montalbano, JoAnne et al. (2010) DOC45, a novel DNA damage-regulated nucleocytoplasmic ATPase that is overexpressed in multiple human malignancies. Mol Cancer Res 8:57-66
He, Qin; Shi, Jinxue; Shen, Xiao-Ling et al. (2010) Dihydroartemisinin upregulates death receptor 5 expression and cooperates with TRAIL to induce apoptosis in human prostate cancer cells. Cancer Biol Ther 9:819-24
Jiang, Lingyan; Sheikh, M Saeed; Huang, Ying (2010) Decision Making by p53: Life versus Death. Mol Cell Pharmacol 2:69-77
Lui, Ki; Huang, Ying (2009) RanGTPase: A Key Regulator of Nucleocytoplasmic Trafficking. Mol Cell Pharmacol 1:148-156